SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001477932-23-003414
Filing Date
2023-05-15
Accepted
2023-05-15 08:01:02
Documents
77
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q ipix_10q.htm   iXBRL 10-Q 1354149
2 CERTIFICATION ipix_ex311.htm EX-31.1 8140
3 CERTIFICATION ipix_ex321.htm EX-32.2 3371
  Complete submission text file 0001477932-23-003414.txt   6038067

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA ipix-20230331.xsd EX-101.SCH 86116
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE ipix-20230331_lab.xml EX-101.LAB 354735
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ipix-20230331_cal.xml EX-101.CAL 52675
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ipix-20230331_pre.xml EX-101.PRE 322883
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ipix-20230331_def.xml EX-101.DEF 228746
71 EXTRACTED XBRL INSTANCE DOCUMENT ipix_10q_htm.xml XML 914727
Mailing Address 301 EDGEWATER PLACE SUITE 100 WAKEFIELD MA 01880
Business Address 301 EDGEWATER PLACE SUITE 100 WAKEFIELD MA 01880 978-921-4125
Innovation Pharmaceuticals Inc. (Filer) CIK: 0001355250 (see all company filings)

IRS No.: 300565645 | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-37357 | Film No.: 23918500
SIC: 2834 Pharmaceutical Preparations